INmune Bio, Inc.
INMB
$6.38
-$0.86-11.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -7.58% | -37.64% | 7.99% | 19.49% | -27.47% |
| Total Receivables | 0.50% | -0.77% | -58.39% | 26.88% | 10.16% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -37.46% | -62.34% | -13.23% | -10.51% | -31.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.51% | -36.79% | 1.00% | 19.01% | -25.33% |
|
|
|||||
| Total Current Assets | -7.51% | -36.79% | 1.00% | 19.01% | -25.33% |
| Net Property, Plant & Equipment | -9.45% | -8.36% | -7.71% | -6.68% | -6.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.97% | -3.66% | 1.23% | -23.58% | -19.08% |
| Total Assets | -4.45% | -25.05% | 0.63% | 12.00% | -17.84% |
|
|
|||||
| Total Accounts Payable | 10.08% | -38.25% | 14.09% | -0.13% | 17.63% |
| Total Accrued Expenses | -- | -54.55% | -60.43% | 148.21% | 60.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.29% | -94.67% | -48.54% | -32.60% | -24.50% |
| Total Finance Division Other Current Liabilities | 12.77% | -5.83% | 5.37% | 0.19% | 6.34% |
| Total Other Current Liabilities | 12.77% | -5.83% | 5.37% | 0.19% | 6.34% |
| Total Current Liabilities | 9.78% | -47.76% | -8.16% | -13.75% | -5.50% |
|
|
|||||
| Total Current Liabilities | 9.78% | -47.76% | -8.16% | -13.75% | -5.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.62% | -14.08% | -11.80% | -10.56% | -9.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.88% | -47.08% | -8.24% | -13.68% | -5.58% |
|
|
|||||
| Common Stock & APIC | 3.75% | 1.13% | 8.28% | 11.09% | 1.12% |
| Retained Earnings | -5.97% | -5.99% | -8.53% | -7.38% | -9.11% |
| Treasury Stock & Other | -6.09% | 44.50% | -45.30% | -6.58% | 16.27% |
| Total Common Equity | -7.55% | -17.01% | 6.60% | 28.55% | -24.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | 0.00% | 0.00% |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -7.55% | -17.01% | 6.60% | 28.55% | -24.41% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.55% | -17.01% | 4.30% | 27.76% | -23.90% |
|
|
|||||